Restart
RestartFINANCING ISSUE
On 1 August, the French commercial court formally agreed on the refinancing plans to help Europlasma continue as is, albeit with new governance and massive dilution. We merely allow for that dilution from now on.
FACT
An ad-hoc Luxemburg based SPV named Zigi Capital and 50/50 owned by MM Alexandre-Henri Carré and Jérôme Garnache-Creuillot has committed to injecting the necessary resources into Europlasma to make it a successful venture. Thoee plans have been accepted by the commercial court. While there is an entirely new governance, the technique used to prop up the funding of Europlasma is massively dilutive as it amounts to de facto_ equity lines.
ANALYSIS
Note that the previous governance had reached the conclusion that equity lines were no longer suitable as the group needed a substantial pocket of long-term funding for its two businesses and particularly for the capital intensive green power activity (CHO Power). If no long-term financing could be found for both, the idea was then to sell one of the businesses.
Zigi adds new layers of equity lines essentially achieved by the issuance of very short-term convertibles immediately converted into equity and sold in the market. Europlasma provided a detailed review of the potential number of shares once all known future layers of financing and payment of commissions to arrangers have been deployed.
As of end June 2019, the number of shares was 285m. We had anticipated 2019 to close at 345m shares prior to the financial restructuring and change of ownership. We now allow for 640m shares for 2019-2020-2021 as our current best guess of nearly-certain dilution
Note that Europlasma filed for Chapter 11 in January 2019 and has yet to publish its 2018 accounts. This means that the dilution is both phenomenal and based on highly theoretical earnings.
IMPACT
The impact on earnings last reviewed in November 2018 (...) is quite mechanical even though it is hardly visible with expected eps ranging from -0.01€ to 0.01€. The target price is divided by three as we have also taken a more cautious view on the DCF.
Europlasma SA. Europlasma SA is a France-based company that offers a range of solutions for hazardous waste treatment. The Company's technology allows converting toxic waste into reusable materials. The Company is composed of four entities, such as Europlasma Torch & Process, which provides engineering consulting for hazardous waste treatment, and sells and licenses its plasma torches and technology; Inertam SAS, which specializes in destruction and valorization of asbestos waste and operates ash melting units; CHO Power SAS, which supplies technological solutions for the efficient transformation of biomass and waste into electric energy and Europe Environnement, which offers ventilation and air cleaning systems for industrial applications.
AlphaValue Corporate Services capitalise on the research and credit analysis expertise deployed by AlphaValue with major institutional investors at European level over the past nine years. The proprietary tools and processes enabling AlphaValue Corporate Services to establish a valuation and/or a credit risk assessment are identical to those used by AlphaValue to the benefit of its institutional clients. The only difference is the recognition that a company evaluation cannot be dissociated from the fact that the latter is paying for the service (AlphaValue Corporate Services), as opposed to the investor footing the bill (AlphaValue). AlphaValue’s research tools are characterised by the transparency of the valuation methodologies, their responsiveness to market data and by nine years’ experience of a universe numbering more than 450 European companies. Through its coverage and sector exhaustiveness, AlphaValue ranks alongside the major research houses in Europe and constitutes the only new entrant to the European space in the past decade. This significant presence is reflected in an unrivalled distribution capability via platforms commonly adopted by investors to access research: Factset, Bloomberg, Capital IQ and the numerous websites. AlphaValue is one the largest research contributors to these platforms, to the benefit of AlphaValue Corporate Services issuer clients. The AlphaValue Corporate Services analysts are AlphaValue’s sector specialists. Their robust knowledge of the business models in their sectors enables the rapid generation of incisive, relevant research and advantageous interaction with the management teams.
Unfortunately, this report is not available for the investor type or country you selected.
Browse all ResearchPool reportsReport is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.